A dual-targeting peptide facilitates targeting anti-inflammation to attenuate atherosclerosis in ApoE-/- mice.
Chem Commun (Camb)
; 58(62): 8690-8693, 2022 Aug 02.
Article
em En
| MEDLINE
| ID: mdl-35833251
We report a peptidic dual-targeting drug delivery platform (integrins targeting and self-assembly instructed by matrix metalloproteinases) towards inflamed endothelial cells, which improved the anti-inflammatory ability of the loaded drug (i.e., puerarin) in vitro and thus improved the antiatherogenic effect of the loaded drug (i.e., puerarin) in vivo.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Células Endoteliais
/
Aterosclerose
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article